Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Auditor change
|
|
Evoke Pharma Inc (EVOK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2023 |
4
| WIDDER KENNETH J (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 14,250 options to buy
@ $2.12, valued at
$30.2k
|
|
| 05/11/2023 |
4
| REED VICKIE S (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 15,000 options to buy
@ $2.12, valued at
$31.8k
|
|
| 05/11/2023 |
4
| Hill Malcolm R (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 14,625 options to buy
@ $2.12, valued at
$31k
|
|
| 05/11/2023 |
4
| GARNER CAM L (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 17,750 options to buy
@ $2.12, valued at
$37.6k
|
|
| 05/11/2023 |
4
| Brady Todd C (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 14,625 options to buy
@ $2.12, valued at
$31k
|
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| WIDDER KENNETH J (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 56,000 options to buy
@ $0.66, valued at
$37k
|
|
| 04/28/2022 |
4
| REED VICKIE S (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 58,000 options to buy
@ $0.66, valued at
$38.3k
|
|
| 04/28/2022 |
4
| Hill Malcolm R (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 57,750 options to buy
@ $0.66, valued at
$38.1k
|
|
| 04/28/2022 |
4
| GARNER CAM L (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 67,500 options to buy
@ $0.66, valued at
$44.6k
|
|
| 04/28/2022 |
4
| Brady Todd C (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 57,750 options to buy
@ $0.66, valued at
$38.1k
|
|
| 02/04/2022 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 175,000 options to buy
@ $0.55, valued at
$96.3k
|
|
| 02/04/2022 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 100,000 options to buy
@ $0.55, valued at
$55k
|
|
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2021 |
4
| WIDDER KENNETH J (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 56,000 options to buy
@ $1.55, valued at
$86.8k
|
|
| 07/23/2021 |
4
| RHOADS ANN D (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 61,750 options to buy
@ $1.55, valued at
$95.7k
|
|
| 07/23/2021 |
4
| Hill Malcolm R (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 54,000 options to buy
@ $1.55, valued at
$83.7k
|
|
| 07/23/2021 |
4
| Brady Todd C (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 57,750 options to buy
@ $1.55, valued at
$89.5k
|
|
| 07/23/2021 |
4
| GARNER CAM L (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 67,500 options to buy
@ $1.55, valued at
$104.6k
|
|
| 05/17/2021 |
4
| REED VICKIE S (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 70,000 options to buy
@ $1.14, valued at
$79.8k
|
|
| 01/29/2021 |
4
| CARLSON MARILYN R. (Chief Medical Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 300,000 options to buy
@ $2.68, valued at
$804k
|
|
| 01/29/2021 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 300,000 options to buy
@ $2.68, valued at
$804k
|
|
| 01/29/2021 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 415,000 options to buy
@ $2.68, valued at
$1.1M
|
|
| 12/14/2020 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Sold 48,046 shares
@ $2.9, valued at
$139.3k
Sold 23,954 shares
@ $2.94, valued at
$70.4k
|
|
| 12/14/2020 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Sold 5,643 shares
@ $2.95, valued at
$16.6k
Sold 40,357 shares
@ $2.91, valued at
$117.4k
|
|
| 12/11/2020 |
4
| Gonyer David A (President and CEO) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Exercised 72,000 options to buy
@ $0.4, valued at
$28.8k
|
|
| 12/11/2020 |
4
| D'Onofrio Matthew J (Exec VP, Chief Bus. Officer) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Exercised 46,000 options to buy
@ $0.4, valued at
$18.4k
|
|
| 09/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2020 |
4
| Hill Malcolm R (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 54,000 options to buy
@ $2.6, valued at
$140.4k
|
|
| 05/29/2020 |
4
| WIDDER KENNETH J (Director) has filed a Form 4 on Evoke Pharma Inc|
Txns:
| Granted 56,000 options to buy
@ $2.6, valued at
$145.6k
|
|
|
|
|